A share price of Korro Bio Inc [KRRO] is currently trading at $23.08, down -2.49%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The KRRO shares have gain 15.17% over the last week, with a monthly amount glided 54.28%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Korro Bio Inc [NASDAQ: KRRO] stock has seen the most recent analyst activity on April 29, 2025, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $74. Previously, Chardan Capital Markets started tracking the stock with Buy rating on April 16, 2025, and set its price target to $25. On January 10, 2025, Oppenheimer initiated with a Outperform rating and assigned a price target of $155 on the stock. Raymond James started tracking the stock assigning a Strong Buy rating and suggested a price target of $153 on October 21, 2024. William Blair initiated its recommendation with a Outperform and recommended $180 as its price target on August 14, 2024. H.C. Wainwright reiterated a Buy rating for this stock on March 28, 2024, and upped its price target to $115. In a note dated February 27, 2024, BMO Capital Markets initiated an Outperform rating and provided a target price of $120 on this stock.
Korro Bio Inc experienced fluctuations in its stock price throughout the past year between $10.29 and $98.00. Currently, Wall Street analysts expect the stock to reach $25 within the next 12 months. Korro Bio Inc [NASDAQ: KRRO] shares were valued at $23.08 at the most recent close of the market. An investor can expect a potential return of 8.32% based on the average KRRO price forecast.
Analyzing the KRRO fundamentals
Gross Profit Margin for this corporation currently stands at 0.67% with Operating Profit Margin at -15.69%, Pretax Profit Margin comes in at -14.53%, and Net Profit Margin reading is -14.54%. To continue investigating profitability, this company’s Return on Assets is posted at -0.51, Equity is -0.62 and Total Capital is -0.6. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.39.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 22.28 points at the first support level, and at 21.47 for the second support level. However, for the 1st resistance point, the stock is sitting at 24.29, and for the 2nd resistance point, it is at 25.50.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Korro Bio Inc [NASDAQ:KRRO] is 5.98. Further, the Quick Ratio stands at 5.98, while the Cash Ratio is 1.96. Considering the valuation of this stock, the price to sales ratio is 34.51, the price to book ratio is 1.88.
Transactions by insiders
Recent insider trading involved Agarwal Vineet, Chief Financial Officer, that happened on Nov 11 ’24 when 800.0 shares were sold. Officer, Agarwal Vineet completed a deal on Nov 11 ’24 to buy 800.0 shares. Meanwhile, Chief Financial Officer Agarwal Vineet sold 10216.0 shares on Oct 17 ’24.
